These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2994158)

  • 1. Selectivity of opioid agonists and antagonists for the various opioid receptor types.
    Takemori AE; Portoghese PS
    Psychopharmacol Bull; 1985; 21(3):464-5. PubMed ID: 2994158
    [No Abstract]   [Full Text] [Related]  

  • 2. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Opioid agonists and antagonists, opioid receptors].
    Holzgrabe U; Nachtsheim C; Siener T; Drosihn S; Brandt W
    Pharmazie; 1997 Jan; 52(1):4-22. PubMed ID: 9082464
    [No Abstract]   [Full Text] [Related]  

  • 4. [Opiates and their antagonists].
    Langwiński R
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1625-9. PubMed ID: 6089154
    [No Abstract]   [Full Text] [Related]  

  • 5. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1989 Annual Report, evaluation of new compounds for opioid activity.
    Woods JH; Medzihradsky F; Smith CB; Winger GD; France CP
    NIDA Res Monogr; 1989; 95():632-79. PubMed ID: 2561858
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of opioids.
    Martin WR
    Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents.
    Zimmerman DM; Leander JD
    J Med Chem; 1990 Mar; 33(3):895-902. PubMed ID: 2155322
    [No Abstract]   [Full Text] [Related]  

  • 10. Delta opioid receptor selective alkaloid agonists and antagonists.
    Woods JH; DeCosta B; Jacobson AE; Rice KC; Medzihradsky F; Smith CB; Comer S; France CP; Winger G
    NIDA Res Monogr; 1989; 95():300-1. PubMed ID: 2561836
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo antagonism of analgesia and respiratory depression induced by proposed mu and kappa opiate agonists [proceedings].
    Metcalf G; Rees JM; Ward SJ
    Br J Pharmacol; 1979 Jul; 66(3):473P-474P. PubMed ID: 230881
    [No Abstract]   [Full Text] [Related]  

  • 12. State-of-the-art analgesics from the agonist-antagonist concept.
    Archer S
    NIDA Res Monogr; 1992; 119():71-5. PubMed ID: 1331799
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of new compounds for opioid activity (1983).
    Woods JH; Winger GD; Medzihradsky F; Smith CB; Katz JL
    NIDA Res Monogr; 1984 Mar; 49():361-7. PubMed ID: 6090918
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
    Rady JJ; Elmer GI; Fujimoto JM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Opiates, opioid receptors and thermoregulatory changes].
    Ovcharov R; Iakimova K
    Eksp Med Morfol; 1984; 23(4):205-10. PubMed ID: 6098438
    [No Abstract]   [Full Text] [Related]  

  • 17. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposed mode of action for narcotic agonists and antagonists.
    Cho TM; Law PY; Loh HH
    Adv Biochem Psychopharmacol; 1979; 20():69-101. PubMed ID: 224664
    [No Abstract]   [Full Text] [Related]  

  • 19. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
    Valentino RJ; Herling S; Woods JH; Medzihradsky F; Merz H
    J Pharmacol Exp Ther; 1981 Jun; 217(3):652-9. PubMed ID: 6262493
    [No Abstract]   [Full Text] [Related]  

  • 20. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.